ArticleFrontiers in cellular and infection microbiology2025
The microbiological features and risk factors for liver abscess after thermal ablation of liver cancer.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: Massive subcapsular hepatic hematoma after spontaneous rupture of pyogenic liver abscess in a healthy young woman.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Liver abscess is a severe complication that can occur following thermal ablation of liver cancer, with an incidence rate ranging from 0.2% to 2.4%. This study aimed to identify risk factors associated with the development of post-ablation liver abscesses and to characterize the microbiological features of the isolated pathogens. Methods: A matched case-control study was conducted at Beijing Youan Hospital from January 2018 to December 2023. Cases were defined as patients who developed liver abscesses within three months following ablation therapy, while controls comprised patients who did not develop such abscesses. Clinical and microbiological data were collected and analyzed. The relevant independent risk factors for the occurrence of liver abscesses were identified and assessed using multivariate logistic regression analysis. Results: Post-ablation liver abscesses predominantly occurred in male patients aged 60 years or older, typically manifesting around six days after the procedure. Common symptoms included fever, chills, abdominal distension, and abdominal pain. Multivariate analysis identified diabetes mellitus (OR=3.215; 95% CI 1.330-7.771), history of abdominal surgery (OR=2.810; 95% CI 1.074-7.353), biliary disease (OR=18.832; 95% CI 2.291-154.795), and elevated ALP levels (OR=1.010; 95% CI 1.002-1.019) as independent risk factors for post-ablation liver abscesses. Among the 61 patients with liver abscesses, a total of 78 bacterial strains were isolated from the abscess fluid, with Gram-negative bacteria accounting for 75.6% of the isolates. Conclusions: Post-ablation liver abscesses are primarily caused by Gram-negative bacteria. A history of diabetes, prior abdominal surgery, biliary disease, and elevated ALP levels are significant risk factors influencing the development of post-ablation liver abscesses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.